Share
CBS News
A long-awaited coronavirus vaccine could be available in roughly two months, according to drugmaker AstraZeneca, which is developing a treatment.
The Anglo-Swedish drugmaker is working with the University of Oxford to develop one of the most closely watched COVID-19 vaccines, which is in late stage trials in the U.S., the U.K. and other countries to determine its safety and effectiveness. Once those results are reported, regulators will have to approve the vaccine for widespread use.
AstraZeneca said it will analyze data from its vaccine trials in November and December. If the results look promising, it will move quickly to ramp up manufacturing and obtain government approval in the U.S. and elsewhere, Chief Executive Pascal Soriot said Thursday.
By Khristopher J. Brooks | 5 Nov 2020
RELATED TOPICS:
Former Vice President Kamala Harris to Be Honored by NAACP With Its Chairman’s Award
6 hours ago
‘Life-Threatening Cold’ Expected as Polar Vortex Stretches Across US
6 hours ago
Where to Chill on the Cheap in the Caribbean
9 hours ago
California’s Aging Population Will Test Whether Its Demography Is Destiny
1 day ago
Delta Plane Flips on Toronto Runway Amid Winter Storm
2 hours ago
Categories

Delta Plane Flips on Toronto Runway Amid Winter Storm

Fresno Joins National Protests Against Trump Administration

Canadian National Anthem Booed, but Only Lightly, at 4 Nations Hockey Tournament

Former Vice President Kamala Harris to Be Honored by NAACP With Its Chairman’s Award

‘Life-Threatening Cold’ Expected as Polar Vortex Stretches Across US
